Yin Weidong, Sinovac CEO (Nicolas Bock/Bloomberg via Getty Images)

Covid-19 roundup: Sino­vac shot com­plete­ly pre­vents se­vere cas­es at 14-day mark, com­pa­ny says

Sino­vac has made some big da­ta claims on its way to a ten­ta­tive ap­proval in Chi­na for its Covid-19 vac­cine. New Phase III da­ta show …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.